About Pfizer Products India Private Limited
Data last updated:
Pfizer Products India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Pharmacia & Upjohn Llc. It operates in the business support services segment of the business services sector. It was incorporated on 19 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1996FTC148003. Its GSTIN is 27AADCP8985B1Z4 (Maharashtra). The company holds 19 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹17.5 Cr and a paid-up capital of ₹17.5 Cr. It was formerly known as Pharmacia India Private Limited. It is led by directors including Seema Shantharam Pai (Whole-Time Director) and Shabbar Abid Vhora (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at The Capital 1802 / 1901 Plot No. C – 70 G Block Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051.
As per the financials filed for FY 2025, the company reported a revenue of ₹723.76 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹41.84 Cr (net margin 5.8%) and EBITDA of ₹61.42 Cr (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.
The company has about 279 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pfizer. As per MCA filings, the company has open charges of ₹1.11 Cr on record. Court records list 84 cases involving the company, including 74 filed by the company and 10 filed against it; 8 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pfizer.com.
Company details
CIN history
Pfizer Products India has one previous CIN (Corporate Identification Number): U24230MH1996PTC148003. The current CIN is U24230MH1996FTC148003, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1996FTC148003 | Current |
| U24230MH1996PTC148003 | Previous |
Contact details
Pfizer Products India Private Limited's registered office is in Mumbai, Maharashtra. Its website is pfizer.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressThe Capital 1802 / 1901 Plot No. C – 70 G Block Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051
- IndustryBusiness Services, Business Support Services
To see the full contact details of Pfizer Products India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Pfizer Products India operates one associated brand: Pfizer. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products for treating multiple diseases are provided. | pfizer.com |
Business activity
The main business activities of Pfizer Products India are trade and support service to organizations. In detail, this covers wholesale trading and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Pfizer Products India Private Limited, buy the company report.
Financials of Pfizer Products India Private Limited
FY 2025 filings availablePfizer Products India Private Limited reported revenue of ₹723.76 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 18% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.42 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.84 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pfizer Products India Private Limited, buy the company report.
Board of directors of Pfizer Products India Private Limited
Pfizer Products India has 3 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Darshak Pradip Bhagat Also directs: Wyeth Pharmaceuticals India Private Limited | Director | 31 Mar 2021 | 5 Years 7 Months | Current |
| Seema Shantharam Pai | Whole-Time Director | 25 Sep 2020 | 6 Years 1 Months | Current |
| Shabbar Abid Vhora | Whole-Time Director | 29 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Pfizer Products India Private Limited is compared with the 4 companies closest to it by revenue in the Business Services industry (Business Auxiliary Services, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jammu and Kashmir Small Scale Industries Development Corporation Limited | ₹748.76 Cr (FY 2018) | 94.0% | Jammu, Jammu and Kashmir, India | |||
| Takeda Biopharmaceuticals India Private Limited | ₹726.51 Cr (FY 2025) | -7.0% | Gurgaon, Haryana, India | |||
| Pfizer Products India Private Limitedthis company | ₹723.76 Cr (FY 2025) | ₹41.84 Cr | 5.8% | 18.0% | 279 | Mumbai, Maharashtra, India |
| Vasu Agencies Drugs Private Limited | ₹682.72 Cr (FY 2025) | 15.0% | Hyderabad, Telangana, India | |||
| Glaxosmithkline Consumer Private Limited | ₹675.32 Cr (FY 2025) | 13.0% | Patiala, Punjab, India |
To see the full peer comparison of Pfizer Products India Private Limited, buy the company report.
Auditor
Pfizer Products India Private Limited is audited by B S R & Co. LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2022 | 101248W/W-100022 |
Shareholding
The shareholding of Pfizer Products India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pfizer Products India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jun 2002 | 90356287 | Corproation Bank | ₹3.5 Lakh | Open | |
| 17 May 2002 | 90356286 | Corproation Bank | ₹3.5 Lakh | Open | |
| 28 Aug 2001 | 90356277 | Corproation Bank | ₹60 Lakh | Open | |
| 25 Jun 2001 | 90356271 | Corproation Bank | ₹2.45 Lakh | Open | |
| 19 Jun 2001 | 90356270 | Corproation Bank | ₹6.15 Lakh | Open |
Total charge records: 8 View all charges
Legal cases
Pfizer Products India Private Limited has 84 court cases on record: 74 filed by Pfizer Products India, 10 filed against it. 8 cases are pending and 76 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 57 | 3 | 5 |
| High courts | 25 | 5 | 3 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 84)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMSS) | Filed by the company against JP Pharma Solutions Pvt Ltd | Disposed |
| District court, Mohali, Punjab | Civil suit | Filed against the company by JP Pharma Solutions Pvt Ltd | Disposed |
| Bombay High Court | Writ petition | Filed against the company by Novo Nordisk India Pvt. Ltd. | Disposed |
| Supreme Court | Court case (2804-Mercantile Laws, Commercial Transactions Including Banking : Trade Marks/Copy Rights/Patents/Design Act) | Filed against the company by SP Accure Labs Private Limited Through Its Authorised Signatory 18-17/1/F-2, City, Home Residency, Road No. 3, Kamala Nagar, Dilshuknagar, , District: Hyderabad ,Hyderabad , Telangana | Disposed |
| Supreme Court | Court case (2804-Mercantile Laws, Commercial Transactions Including Banking : Trade Marks/Copy Rights/Patents/Design Act) | Filed against the company by Accure Labs Pvt Ltd Through Its Authorised Signatory Flat No. 1406A, 14Th Floor, Building No. 89, Hemkunth Chamber, Nehru Place, New Delhi ,New Delhi , Delhi | Disposed |
To see the full case history of Pfizer Products India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Pfizer Products India Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 34 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| River Route Creative Group LLP | |||
| Webstream Communications Private Limited | |||
| an individual supplier | |||
| Navina Print Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Pfizer Products India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Pfizer Products India Private Limited has a workforce of 279 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Pfizer Products India has 19 GST registrations: 14 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCP8985B1Z4 | Maharashtra | Active | 01 Jul 2017 |
| 03AADCP8985B1ZE | Punjab | Active | 01 Jul 2017 |
| 06AADCP8985B1Z8 | Haryana | Active | 01 Jul 2017 |
| 08AADCP8985B1Z4 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pfizer Products India Private Limited, buy the company report.
Recent activity
Pfizer Products India Private Limited has 21 board changes on record since 2006: 4 appointments and 17 cessations. The latest: Darshak Pradip Bhagat ceased to be Additional Director on 29 Sep 2021.
20 earlier events are in the company report.
News
Frequently asked questions
Pfizer Products India is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in business support services, within the business services industry. It was incorporated on 19 December 1996 (30+ years old) and is registered under CIN U24230MH1996FTC148003.
Pfizer Products India has 3 current directors:
- Seema Shantharam Pai - Whole-Time Director
- Shabbar Abid Vhora - Whole-Time Director
- Darshak Pradip Bhagat - Director
The latest financial statements of Pfizer Products India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pfizer Products India is 27AADCP8985B1Z4, registered in Maharashtra. The company has 19 GST registrations in all, of which 14 are active and 5 are cancelled or inactive. Other active GSTINs include 03AADCP8985B1ZE (Punjab), 06AADCP8985B1Z8 (Haryana), 08AADCP8985B1Z4 (Rajasthan).
The CIN (Corporate Identification Number) of Pfizer Products India is U24230MH1996FTC148003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pfizer Products India has 84 court cases on record: 74 filed by the company and 10 filed against it. 8 are pending. Most are in the district courts.
Pfizer Products India was incorporated on 19 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pfizer Products India by revenue are Jammu and Kashmir Small Scale Industries Development Corporation Limited, Takeda Biopharmaceuticals India Private Limited, Vasu Agencies Drugs Private Limited, Glaxosmithkline Consumer Private Limited, all in the Business Services industry (Business Auxiliary Services, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Darshak Pradip Bhagat ceased to be Additional Director on 29 Sep 2021. Shabbar Abid Vhora was appointed as Whole-Time Director on 29 Sep 2021. Shabbar Abid Vhora ceased to be Whole-Time Director on 28 Sep 2021. Pfizer Products India has 21 board changes on record in total.
Pfizer Products India has 12 MSME Form 1 returns on record between 2019 and 2024, listing 34 overdue payments to 15 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Pfizer Products India can be reached through the website pfizer.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Pfizer Products India is at The Capital 1802 1901 Plot No. C – 70 G Block Bandra Kurla Complex Bandra East, Mumbai, Maharashtra, India – 400051.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
